Yang Q, Zhou Z, Li L, Lu R, Hou G, Huang C
Nucleic Acids Res. 2025; 53(4).
PMID: 39988317
PMC: 11840553.
DOI: 10.1093/nar/gkaf107.
Guo Y, Yu Y, Wang G
Cancer Treat Res. 2023; 190:273-320.
PMID: 38113005
DOI: 10.1007/978-3-031-45654-1_9.
Yang B, Zhang W, Sun L, Lu B, Yin C, Zhang Y
iScience. 2023; 26(5):106684.
PMID: 37182100
PMC: 10173731.
DOI: 10.1016/j.isci.2023.106684.
Bhattacharyya T, Bond J
Cancers (Basel). 2023; 15(6).
PMID: 36980579
PMC: 10046783.
DOI: 10.3390/cancers15061693.
Hanot M, Raby L, Volkel P, Le Bourhis X, Angrand P
Int J Mol Sci. 2023; 24(3).
PMID: 36768643
PMC: 9916924.
DOI: 10.3390/ijms24032322.
Molecular Cloning and Expression Responses of to High-Temperature Treatment in Nile Tilapia ().
Zhou M, Yao Z, Zhao M, Fang Q, Ji X, Chen H
Genes (Basel). 2022; 13(10).
PMID: 36292604
PMC: 9602145.
DOI: 10.3390/genes13101719.
Modulation of the high-order chromatin structure by Polycomb complexes.
Guo Y, Wang G
Front Cell Dev Biol. 2022; 10:1021658.
PMID: 36274840
PMC: 9579376.
DOI: 10.3389/fcell.2022.1021658.
The epigenetic state of EED-Gli3-Gli1 regulatory axis controls embryonic cortical neurogenesis.
Zhang S, Dai S, Du H, Wang H, Li X, Tang Y
Stem Cell Reports. 2022; 17(9):2064-2080.
PMID: 35931079
PMC: 9481917.
DOI: 10.1016/j.stemcr.2022.07.004.
Bioinformatics analysis of potential therapeutic targets for COVID-19 infection in patients with carotid atherosclerosis.
Yanchao L, Sibin Z, Gareev I, Huan X, Junfei Z, Chunyang L
J Infect Public Health. 2022; 15(4):437-447.
PMID: 35344771
PMC: 8937610.
DOI: 10.1016/j.jiph.2022.03.004.
Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments.
Mieczkowska I, Pantelaiou-Prokaki G, Prokakis E, Schmidt G, Muller-Kirschbaum L, Werner M
Cell Death Dis. 2021; 12(12):1118.
PMID: 34845197
PMC: 8630036.
DOI: 10.1038/s41419-021-04407-y.
Structural insights into the interactions of Polycomb Repressive Complex 2 with chromatin.
Iragavarapu A, Yao L, Kasinath V
Biochem Soc Trans. 2021; 49(6):2639-2653.
PMID: 34747969
PMC: 10284349.
DOI: 10.1042/BST20210450.
Polycomb Factor PHF19 Controls Cell Growth and Differentiation Toward Erythroid Pathway in Chronic Myeloid Leukemia Cells.
Garcia-Montolio M, Ballare C, Blanco E, Gutierrez A, Aranda S, Gomez A
Front Cell Dev Biol. 2021; 9:655201.
PMID: 33996816
PMC: 8116664.
DOI: 10.3389/fcell.2021.655201.
MiR-199-3p enhances muscle regeneration and ameliorates aged muscle and muscular dystrophy.
Fukuoka M, Fujita H, Numao K, Nakamura Y, Shimizu H, Sekiguchi M
Commun Biol. 2021; 4(1):427.
PMID: 33782502
PMC: 8007565.
DOI: 10.1038/s42003-021-01952-2.
Re-expression of miR-200s in claudin-low mammary tumor cells alters cell shape and reduces proliferation and invasion potentially through modulating other miRNAs and SUZ12 regulated genes.
Simpson K, Conquer-van Heumen G, Watson K, Roth M, Martin C, Moorehead R
Cancer Cell Int. 2021; 21(1):89.
PMID: 33541373
PMC: 7863273.
DOI: 10.1186/s12935-021-01784-4.
Polycomb Gene Silencing Mechanisms: PRC2 Chromatin Targeting, H3K27me3 'Readout', and Phase Separation-Based Compaction.
Guo Y, Zhao S, Wang G
Trends Genet. 2021; 37(6):547-565.
PMID: 33494958
PMC: 8119337.
DOI: 10.1016/j.tig.2020.12.006.
Long noncoding RNA MEG3 blocks telomerase activity in human liver cancer stem cells epigenetically.
Jiang X, Wang L, Xie S, Chen Y, Song S, Lu Y
Stem Cell Res Ther. 2020; 11(1):518.
PMID: 33256840
PMC: 7706068.
DOI: 10.1186/s13287-020-02036-4.
A Structural Perspective on Gene Repression by Polycomb Repressive Complex 2.
Liu X
Subcell Biochem. 2020; 96:519-562.
PMID: 33252743
DOI: 10.1007/978-3-030-58971-4_17.
The Lineage Before Time: Circadian and Nonclassical Clock Influences on Development.
Bedont J, Iascone D, Sehgal A
Annu Rev Cell Dev Biol. 2020; 36:469-509.
PMID: 33021821
PMC: 10826104.
DOI: 10.1146/annurev-cellbio-100818-125454.
The Polycomb-associated factor PHF19 controls hematopoietic stem cell state and differentiation.
Vizan P, Gutierrez A, Espejo I, Garcia-Montolio M, Lange M, Carretero A
Sci Adv. 2020; 6(32):eabb2745.
PMID: 32821835
PMC: 7406347.
DOI: 10.1126/sciadv.abb2745.
NCBP3/SNHG6 inhibits GBX2 transcription in a histone modification manner to facilitate the malignant biological behaviour of glioma cells.
Li X, Zhang F, Ma J, Ruan X, Liu X, Zheng J
RNA Biol. 2020; 18(1):47-63.
PMID: 32618493
PMC: 7833770.
DOI: 10.1080/15476286.2020.1790140.